ArticleClinicoEconomics and outcomes research : CEOR2017

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA.

Naomi V Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.